Back to announcement
20250618_MERK_Ringkasan Risalah//Risalah RUPS_31896400_lamp4.pdf
RUPS minutes Needs review MERKSource file signed link, expires in 15 minutes
Extracted text 3
Page 1
PT Merck Tbk
SUMMARY OF MINUTES OF
ANNUAL GENERAL MEETING OF SHAREHOLDERS
The Board of Directors of PT Merck Tbk (the “Company”) hereby notifies the Company’s Shareholders that
the Company has held the Annual General Meeting of Shareholders (the ”Meeting”) by physically as well as
electronically (“e-RUPS”) through eASY.KSEI and the Meeting livestream through zoom webinar
AKSes.KSEI facility as provided by PT Kustodian Sentral Efek Indonesia. The Summary of the Minutes of the
Meeting are as follows:
Day, date : Monday, June 16, 2025
Time : 10.15 – 11.26 Western Indonesia Time
Venue : the Company’s premises, Jl. TB. Simatupang No. 8, Pasar Rebo, Jakarta Timur
The Meeting Agenda
1. Approval of the Report of the Board of Directors and the Board of Commissioners regarding the
management and financial administration of the Company for the financial year ended on December 31,
2024 and Approval of the Statements of Financial Position of the Company per December 31, 2024 and
Statements of Profit or Loss and Other Comprehensive Income of the Company for the financial year
ended on December 31, 2024, and provide acquit et de charge to the members of the Board of Directors
for all management actions and the exercise of authority by the members of the Board of Directors and
to the members of the Board of Commissioners for the supervisory actions of the members of the Board
of Commissioners during the financial year ended on December 31, 2024.
2. Stipulation on the use of profits of the Company.
3. Appointment of Public Accountant for the financial year ended on the December 31, 2024 and to empower
the Board of Commissioners to stipulate the honorarium of Public Accountant and other requirements for
its designation.
The Meeting was attended by members of the Company’s Board of Directors, namely:
1. Mrs. Evie Yulin (President Director);
2. Mr. Arryo Aritrixso Teguh Putranto Wachjuwidajat (Director); and
3. Mr. Bambang Nurcahyo (Director).
The Meeting was attended by Shareholders and/or their Proxies representing 389,121,821 shares or 86.86%
of 448,000,000 shares which has been issued by the Company.
During the Meeting Agenda discussion, the shareholders and/or their proxies who attend physically or
electronically were given the opportunity to ask the questions, opinions, proposals and/or suggestions related
to the agenda of the Meeting are discussed prior the voting sessions.
The resolution making mechanism carried out by verbal and asked to the shareholders and/or their proxies
who physically attend in the Meeting to raise their hands for those vote objections and abstains, while those
vote approve is not being asked to raise their hands. Abstains vote is considered to the same vote as majority
of the voting shareholders. For Shareholders who attend through eASY.KSEI, Meeting resolutions are made
by selecting decisions available on the eASY.KSEI platform that started within 1 (one) minute since the
Meeting Chairman determined to start for the voting time.
Page 1 of 3
Page 2
PT Merck Tbk
Number of Total Vote
Shareholders
Meeting
and/or their
Agenda
Proxies who Agree Disagree Abstain Total Agree + Abstain Result
raised question
389,121,721 shares 100 shares 389,121,721 shares
1 3 (99.99997% of total 0,00003% of total 0 (99.99997% of total Approved
shares present at the shares present at shares present at the
meeting) the meeting) meeting)
389,121,721 shares 100 shares 389,121,721 shares
2 0 (99.99997% of total 0,00003% of total 0 (99.99997% of total Approved
shares present at the shares present at shares present at the
meeting) the meeting) meeting)
389,121,721 shares 100 shares 389,121,721 shares
3 0 (99.99997% of total 0,00003% of total 0 (99.99997% of total Approved
shares present at the shares present at shares present at the
meeting) the meeting) meeting)
Meeting Resolutions
1. The First Agenda:
a. Approved the Annual Report of the Company’s Board of Directors and Board of Commissioners for the
year ended on December 31, 2024.
b. Approved and ratified the Statement of Financial Position as well as Statement of Profit or Loss and
Other Comprehensive Income of the Company for the financial year ended on December 31, 2024
and grant the acquit et de charge to members of the Board of Directors of the Company for all the
management actions and exercise of authority by members of the Board of Directors, also to members
of the Board of Commissioners of the Company for the supervisory actions of the members of the
Board of Commissioners during the Company’s financial year ended on December 31, 2024.
2. The Second Agenda:
a. Approved the use of the Company’s profits for financial year 2024 by distributing the Final Dividend
for the accounting year of 2024 amounting to Rp 170.- (one hundred seventy Rupiah) per share and
approved the distribution procedures of the said Final Dividend to Shareholders/Owner of 448,000,000
(four hundred forty eight million) shares issued by the Company, whose names are registered in the
Shareholders Register of the Company on June 26, 2025 at 16.00 Western Indonesia Time (Recording
Date), in accordance with the regulations of PT Bursa Efek Indonesia (“Stock Exchange”) for trading
shares on the Stock Exchange, as follows:
Cum Final Dividend at Regular and Negotiated Market June 24, 2025
Ex Final Dividend at Regular dan Negotiated Market June 25, 2025
Cum Final Dividend at Cash Market June 26, 2025
Ex Final Dividend at Cash Market June 30, 2025
Recording Date June 26, 2025
Effective Payment Date of Final Dividend July 15, 2025
b. Grants the power of attorney to the Board of Directors of the Company to carry out the said dividend
distribution.
Page 2 of 3
Page 3
PT Merck Tbk
3. The Third Agenda:
a. Approved the appointment of Public Accountant Firm Liana Ramon Xenia & Rekan (“LRX”) to perform
audit of the Company's financial statements as of and for the year ending December 31, 2025. LRX
is a member (as such term is used in Regulation of the Ministry of Finance Number 186/PMK.01/2021
and Regulation of the Financial Services Authority Number 9 of 2023 (the “Relevant Law”)) of Deloitte
Southeast Asia Limited (“DSEAL”). DSEAL is the registered Foreign Audit Organisation (“Organisasi
Audit Asing” or “OAA”) to LRX for the purposes of the Relevant Law. LRX is a legally separate and
independent entity liable for its own acts and omissions and it cannot obligate or bind DSEAL in
respect of third parties.
b. Approve to empower the Company’s Board of Commissioners to determine the fees for the appointed
Public Accounting Firm and to appoint and designate substitute Public Accounting Firm and/or Public
Accountants if for any reason the appointed Public Accounting Firm and/or Public Accountants are
unable to complete the audit of the financial statements in a timely manner.
Jakarta, June 18, 2025
Board of Directors of the Company
Page 3 of 3
Names mentioned 11 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT Kustodian Sentral Efek Indonesia
p.1
unresolved
org
PT Kustodian Sentral Efek Indonesia. The Summary
p.1
unresolved
person
Evie Yulin
p.1
unresolved
person
Arryo Aritrixso Teguh Putranto Wachjuwidajat
p.1
unresolved
person
Bambang Nurcahyo
p.1
unresolved
org
Public Accountant Firm Liana Ramon Xenia & Rekan
p.3
unresolved
org
Ministry of Finance
p.3
unresolved
org
Financial Services Authority
p.3
unresolved
org
Deloitte Southeast Asia Limited
p.3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
Rule parser
Needs review
confidence 0.000
512 ms
12 Sep 2026 22:38
no RUPS minutes content - likely misclassified